Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2동종 CoronaVac 또는 ChAdOx1을 사용한 백신 접종 및 BNT162b2를 사용한 이종 3차 접종에 대한 체액 및 세포 반응Comment Published on 2022-06-012022-09-12 Journal: The Journal of Infection [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abstract antibodies BNT162b2 booster cellular response ChAdOx1 CoronaVac COVID-19 dose Heterologous homologous Interferon-gamma Neutralizing SARS-CoV-2 vaccination Vaccine [DOI] 10.1016/j.jinf.2022.02.026 PMC 바로가기 [Article Type] Comment
Data on immunogenicity and reactogenicity to COVID-19 vaccination among patients receiving maintenance dialysisData article Published on 2022-06-012022-10-05 Journal: Sensors (Basel, Switzerland) [Category] 변종, [키워드] acute respiratory syndrome assays cellular Cellular immune response Complete coronavirus coronavirus disease COVID-19 COVID-19 vaccination dialysis dose Effectiveness ELISPOT exclusion General population Hemodialysis homologous humoral immune response immune response Immunity immunoassay immunoglobulins increased risk interferon-γ Microparticle morbidity and mortality Patient Peritoneal dialysis produced reactogenicity receiving regimen SARS-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 vaccine single dose T cells tested the vaccine trials vaccination [DOI] 10.1016/j.dib.2022.108271 [Article Type] Data article
Strategies and safety considerations of booster vaccination in COVID-19COVID-19에서 추가 백신 접종의 전략 및 안전 고려 사항Review Published on 2022-06-012022-09-11 Journal: Bosnian Journal of Basic Medical Sciences [Category] Coronavirus, COVID19(2023년), SARS, 변종, [키워드] addition approaches booster booster vaccination breakthrough infections combination vaccine COVID-19 COVID-19 pandemic Diseases Effectiveness Efficacy groups Heterologous homologous Immune escape immunization strategies Immunocompromised persistence priority Protective reducing mortality SARS-CoV-2 vaccine SARS-CoV-2 vaccines SARS-CoV-2 variant SARS-CoV-2 variants Strategy vaccination Vaccine [DOI] 10.17305/bjbms.2021.7082 PMC 바로가기 [Article Type] Review
Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort studyObservational Study Published on 2022-05-312022-10-05 Journal: BMC Infectious Diseases [Category] Coronavirus, 임상, [키워드] adjusted Adverse Adverse drug reaction age age and sex AstraZeneca BNT162b2 boost ChAdOx1 Cohort comparable Complete COVID-19 dose Efficacy Factor Frequency Gender Health Heterologous homologous immunization individual Moderna mRNA vaccine mRNA-1273 mRNA-vaccine mRNA-vaccines Observational cohort study observational study pandemic participant problem proportion reaction reactogenicity regimen regimens reported resource survey vaccination Vaccines were assessed with COVID-19 [DOI] 10.1186/s12879-022-07443-x PMC 바로가기 [Article Type] Observational Study
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2BA.2 및 BA.3 SARS-CoV-2에 대한 Omicron BA.1의 교차 중화Article Published on 2022-05-262022-09-12 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] COVID-19 vaccine cross-neutralization Frequency geometric mean titer GMT GMTs Heterologous homologous human sera implication initial neutralization neutralize Neutralizing omicron replaced responsible SARS-CoV-2 sera [DOI] 10.1038/s41467-022-30580-5 PMC 바로가기 [Article Type] Article
The SARS-CoV-2 main protease doesn’t induce cell death in human cells in vitroSARS-CoV-2 주요 프로테아제는 시험관 내에서 인간 세포에서 세포 사멸을 유도하지 않습니다Article Published on 2022-05-242022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 치료기술, 치료제, [키워드] 3CL 3CLpro acute respiratory syndrome acute respiratory syndrome coronavirus addition analyzed antiviral therapies Apoptosis Cell cell death cell line cell lines contribute coronavirus coronavirus disease Coronavirus disease 2019 Coronavirus replication COVID-19 Cytopathic effect cytotoxicity detect develop effective enzyme expression homologous human cell human cell lines in vitro inactivated induce molecular mechanism molecular mechanisms morphology multifunctional Pathogenesis protease Protein proteolytic activity required SARS-CoV SARS-CoV-2 SARS-CoV-2 main protease SARS-CoV-2 pathogenesis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 shown Spread the SARS-CoV-2 therapeutic target unlikely variant viability viral infection [DOI] 10.1371/journal.pone.0266015 PMC 바로가기 [Article Type] Article
Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data이종 불활성화 및 아데노바이러스 매개 COVID-19 백신의 면역원성: 실제 데이터Article Published on 2022-05-202022-09-11 Journal: Vaccine [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] adenoviral-vectored vaccine adenoviral-vectored vaccines Anti-RBD IgG AZD1222 B.1.1.7 B.1.351 B.1.617.2 CMIA CoronaVac country COVID-19 COVID-19 vaccine elicited ELISA enrolled enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay followed by group Heterologous heterologous vaccine homologous IgG immunoassay immunogenicity inactivated Limited Microparticle neutralization test Neutralizing activity neutralizing antibody participant recipient recipients regimen response SARS-CoV-2 SARS-CoV-2 variants sera serum sample serum samples subset surrogate virus neutralization test sVNT tested the SARS-CoV-2 Vaccine variant variants variants of concern virus neutralization test was tested Wuhan Wuhan strain [DOI] 10.1016/j.vaccine.2022.04.043 PMC 바로가기 [Article Type] Article
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster dosesCovishield(아데노바이러스 매개 중증 급성 호흡기 증후군 코로나바이러스 2 백신)의 첫 번째 접종 후 안면 혈관부종: 두 번째 및 세 번째 추가 접종 후 추적Case Reports Published on 2022-05-202022-09-12 Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome allergy Angioedema booster dose ChAdOx1 contribute coronavirus doses drug facial first dose Follow-up full-length Heterologous homologous hypersensitivity mass pandemic reaction SARS-CoV-2 simian adenovirus vector Spike protein vaccination Vaccine Vaccines was recorded [DOI] 10.1590/0037-8682-0063-2022 PMC 바로가기 [Article Type] Case Reports
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variantsSARS-CoV-2 바이러스 변이체에 대한 백신 유도 전신 및 점막 T 세포 면역Article Published on 2022-05-172022-09-11 Journal: Proceedings of the National Academy of Sciences of [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, 치료제, [키워드] absence antibodies B1.351 CD4 CD4 T cell CD4 T cells CD8 T cell CD8 T cells CLARITY conserved COVID-19 vaccine Critical detectable effective Effectiveness elicit epitope Epitopes evade homologous Hospitalization Immunity immunization implication Infection knowledge lack lung immunopathology Lung pathology memory memory T cell memory T cells mucosal neutralized Neutralizing antibodies presence of antibody presence or absence PROTECT Protective protective vaccines provided SARS-CoV-2 SARS-CoV-2 vaccines SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 viral T cell T cell responses T cells Vaccine variant Viral viral control virus virus-neutralizing antibodies [DOI] 10.1073/pnas.2118312119 PMC 바로가기 [Article Type] Article
Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review아데노바이러스 벡터화 및 mRNA COVID-19 백신을 사용한 이종 대 상동 프라임-부스트 일정의 면역원성 및 안전성: 체계적인 검토Review Published on 2022-05-132022-09-12 Journal: Infectious Diseases of Poverty [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Analysis Anti-spike BNT ChAdOx1 nCoV-19 comparable coronavirus disease COVID-19 COVID-19 vaccines database Evidence Heterologous heterologous prime-boost heterologous vaccination higher risk homologous Homologous vaccination immunogenicity Local local reaction Messenger RNA Meta-analysis mRNA mRNA-1273 neutralizing antibody Participants Protein reactogenicity risk Safety searched serum antibody spike-specific T cell supported systematic review systemic reaction T cell vaccination Vaccine Web of Science [DOI] 10.1186/s40249-022-00977-x PMC 바로가기 [Article Type] Review